AI assistant
Sending…
NovaBay Pharmaceuticals, Inc. — Director's Dealing 2011
Sep 14, 2011
35098_dirs_2011-09-13_e0c996ac-48b8-4a3d-a06f-cc85ad94611c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NovaBay Pharmaceuticals, Inc. (NBY)
CIK: 0001389545
Period of Report: 2011-09-12
Reporting Person: Freiman Paul E. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-09-12 | Common Stock | P | 3000 | $0.84 | Acquired | 15137 | Indirect |
More from NovaBay Pharmaceuticals, Inc.
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Annual Report
2026
Mar 19
Regulatory Filings
2026
Feb 20
Regulatory Filings
2026
Feb 12
Proxy Solicitation & Information Statement
2026
Feb 10